How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics
- 31 March 2012
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 39 (3), 187-192
- https://doi.org/10.1016/j.ijantimicag.2011.11.002
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Using PK/PD to Optimize Antibiotic Dosing for Critically Ill PatientsCurrent Pharmaceutical Biotechnology, 2011
- Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic ShockCritical Care Clinics, 2011
- Pharmacokinetics and pharmacodynamics in critically ill patientsCurrent Opinion In Anesthesiology, 2010
- Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill PatientsAntimicrobial Agents and Chemotherapy, 2010
- Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006Antimicrobial Agents and Chemotherapy, 2008
- Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use ProgrammeClinical Pharmacokinetics, 2003
- Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness AnalysisTherapeutic Drug Monitoring, 1999
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory ConcentrationThe Journal of Infectious Diseases, 1987
- INFLUENCE OF BINDING ON THE PHARMACOLOGIC ACTIVITY OF ANTIBIOTICSAnnals of the New York Academy of Sciences, 1973